3 August 2019 - The National Party says a parliamentary report into PHARMAC's funding of cancer drugs was flawed from the beginning.

The Health Select Committee has rejected a petition that asked it to push the agency into funding two breast cancer drugs.

"Its decision-making process is robust and evidence-based," the committee's report, released on Friday, said.

"We do not believe that Parliament should attempt to influence PHARMAC towards funding particular medicines."

Read Newshub article